跳至主要内容
临床试验/NCT03615885
NCT03615885已完成不适用

Acute Cardio-metabolic Responses to Different Forms of Montmorency Tart Cherry Supplementation in Humans With Metabolic Syndrome

University of Hertfordshire2 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2017年6月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
11
试验地点
2
主要终点
Change in Fasting Insulin

研究概览

简要总结

The present study examined the effect of Montmorency tart cherry juice and capsules on functional and blood-based cardio-metabolic markers in humans with Metabolic Syndrome. Participants received a single bolus of Montmorency tart cherry juice, Montmorency tart cherry capsules and placebo in a random, crossover trial. Outcome variables were measured immediately pre- and up to 5 hours post-bolus. It was hypothesised that Montmorency tart cherry juice and capsules would improve cardio-metabolic markers. Furthermore, it was hypothesised that Montmorency tart cherry capsules would be more beneficial than Montmorency tart cherry juice due to increased bioavailability of phytochemicals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Non-smoker,
  • Meet 3 of 5 criteria for Metabolic Syndrome based on National Cholesterol Education Program-Adult Treatment Panel III guidelines:
  • Waist Circumference: >102cm (men), >88cm (women)
  • Fasting Serum Triglycerides: ≥1.69 mmol.L-1
  • Fasting High Density Lipoprotein: <1.03 mmol.L-1 (men), <1.29 mmol.L-1 (women)
  • Blood Pressure: ≥130 mmHg SBP or ≥85 mmHg DBP
  • Fasting Plasma Glucose: ≥6.1 mmol.L-1

排除标准

  • Current or previous history of gastrointestinal, cardiovascular, hepatic or renal disease, currently diagnosed with diabetes or uncontrolled hypertension (≥160/100 mmHg), allergy to maltodextrin or specific fruit products and those currently taking medication (such as steroids, NSAIDs, antibiotics, antihypertensive, hypoglycaemic, lipid-lowering drugs) or currently using any nutritional or antioxidant supplement. Heavy alcohol consumption (>14 units per week).

结局指标

主要结局

Change in Fasting Insulin

时间窗: Pre-Bolus and Post-Bolus (1hr, 3hr, 5hr)

Change in Systolic and Diastolic Blood Pressure

时间窗: Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr)

Change in Fasting Lipid Profile (Total Cholesterol, HDL, Triglycerides, LDL)

时间窗: Pre-Bolus and Post-Bolus (1hr, 3hr, 5hr)

Change in Fasting Glucose

时间窗: Pre-Bolus and Post-Bolus (1hr, 3hr, 5hr)

次要结局

  • Change in Heart Rate(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))
  • Change in Augmentation Index(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))
  • Change in Cardiac Output(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))
  • Change in Stroke Volume(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))
  • Change in Aortic Systolic and Diastolic Pressure(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))
  • Change in Mean Arterial Pressure(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))
  • Change in Resting Energy Expenditure(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))
  • Change in Augmentation Pressure(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))
  • Change in Total Peripheral Resistance(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))
  • Change in Respiratory Quotient(Pre-Bolus and Post-Bolus (30min, 1hr, 2hr, 3hr, 4hr, 5hr))

研究者

发起方
University of Hertfordshire
申办方类型
Other
责任方
Principal Investigator
主要研究者

Terun Desai

PhD Student

University of Hertfordshire

研究点 (2)

Loading locations...

相似试验